高级搜索
罗文卿, 李源奇, 叶飞, 李强明, 张国庆, 李向楠. 肺腺癌患者列线图预后模型的构建与验证[J]. 肿瘤防治研究, 2022, 49(3): 197-204. DOI: 10.3971/j.issn.1000-8578.2022.21.0623
引用本文: 罗文卿, 李源奇, 叶飞, 李强明, 张国庆, 李向楠. 肺腺癌患者列线图预后模型的构建与验证[J]. 肿瘤防治研究, 2022, 49(3): 197-204. DOI: 10.3971/j.issn.1000-8578.2022.21.0623
LUO Wenqing, LI Yuanqi, YE Fei, LI Qiangming, ZHANG Guoqing, LI Xiangnan. Construction and Validation of A Nomogram Prognostic Model for Patients with Lung Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2022, 49(3): 197-204. DOI: 10.3971/j.issn.1000-8578.2022.21.0623
Citation: LUO Wenqing, LI Yuanqi, YE Fei, LI Qiangming, ZHANG Guoqing, LI Xiangnan. Construction and Validation of A Nomogram Prognostic Model for Patients with Lung Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2022, 49(3): 197-204. DOI: 10.3971/j.issn.1000-8578.2022.21.0623

肺腺癌患者列线图预后模型的构建与验证

Construction and Validation of A Nomogram Prognostic Model for Patients with Lung Adenocarcinoma

  • 摘要:
    目的 基于SEER数据库的大样本数据,构建肺腺癌患者生存预后的列线图预测模型。
    方法 回顾性分析SEER数据库收集的2010—2015年诊断为肺腺癌患者的临床数据。根据影响肺腺癌患者预后的独立因素,采用Lasso Cox回归分析构建列线图模型。C指数和校准曲线评估列线图的判别和校准能力。使用NRI和DCA曲线评估列线图的预测能力和净收益。
    结果 共确定了15个影响肺腺癌预后的独立危险因素,并将其整合到列线图模型中。预测模型建模组的C指数为0.819,验证组的C指数为0.810。建模组和验证组校准曲线预测的1、3和5年特异性生存率与实际特异性生存率吻合较好。NRI和DCA曲线表明,列线图预测模型的预测能力和净收益均优于第7版AJCC TNM分期系统。以此模型构建的风险分层模型能够很好地区分出不同风险的患者(P < 0.0001)。
    结论 成功构建并验证了列线图预测模型,为肺腺癌患者的生存预测提供了一个简便可靠的工具。同时,预测模型构建的风险分层模型可以便捷地筛选不同风险的患者,对肺腺癌患者的个体化治疗具有重要的意义。

     

    Abstract:
    Objective To construct a nomogram prognostic model for predicting the survival of patients with lung adenocarcinoma based on the large sample data from the SEER database.
    Methods We retrospectively analyzed the clinical data of patients who were diagnosed with lung adenocarcinoma from 2010 to 2015 in the SEER database. A nomogram model was created based on independent parameters influencing the prognosis of patients with lung adenocarcinoma using Lasso Cox regression analysis. The C-index and calibration curve were utilized to assess the ability to distinguish and calibrate the nomogram. NRI and DCA curves were used to evaluate the prediction ability and net benefit of the nomogram.
    Results A total of 15 independent risk factors affecting the prognosis of lung adenocarcinoma were identified and integrated into the nomogram model. The C-index of the prediction model was 0.819 in the training cohort and 0.810 in the validation cohort. The predicted specific survival rate of the 1-, 3- and 5-year calibration curves of the training cohort and the validation cohort were consistent with the actual specific survival rate. In comparison to the 7th edition of the AJCC TNM staging system, the NRI and DCA curves demonstrated a considerable boost to the predictive capacity and net benefits achieved by the nomogram model. The risk stratification model constructed with this nomogram model was able to distinguish the patients with different risks well (P < 0.0001).
    Conclusion A nomogram prognostic model is successfully developed and validated, which provides a simple and reliable tool for the survival prediction of the patients with lung adenocarcinoma. Meanwhile, the risk stratification model constructed by the prediction model can conveniently screen patients with different risks, which is important for the individualized treatment of lung adenocarcinoma patients.

     

/

返回文章
返回